JDD Corner

JDD November 2024 Issue Highlights | Special Focus: Lasers, Light Sources, and Devices

The November Journal of Drugs in Dermatology Editor’s Picks spotlight the dynamic intersection of Lasers, Light Sources, and Devices in dermatology, featuring a mix of insightful studies and discussions. This month’s selections include an intriguing national survey capturing over 190 dermatologists’ perspectives on the role of AI chatbots in dermatology, examining the potential applications, benefits, and risks these tools pose for patient care. Among other highlights, a comprehensive review sheds light on the efficacy of ablative lasers in treating rhinophyma, while another explores the value of Isobutylamido Thiazolyl Resorcinol (Thiamidol) in managing hyperpigmentation. From new treatments for hidradenitis suppurativa to the latest recommendations on visible light protection, these picks bring fresh perspectives and evidence-based insights on device-driven advancements in dermatology.

Physician Opinions on Artificial Intelligence Chatbots in Dermatology: A National Online Cross-Sectional Survey of Dermatologists categorizes the attitudes and beliefs of over 190 American dermatologists towards AI Chatbots and their potential uses, benefits, and risks.

From CO2 to Er:YAG: A Comprehensive Review of Laser Treatments for Rhinophyma analyzes and shares the promising evidence behind ablative lasers in treating rhinophyma.

Isobutylamido Thiazolyl Resorcinol (Thiamidol) for Combatting Hyperpigmentation: A Systematic Review of Clinical Studies proposes how ITR may serve as a safe and efficacious adjunct or alternative therapeutic option for various hyperpigmentation disorders.

Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey presents and discusses the beneficial observations of one-daily CAB treatment from 6 cases of a 12-week study.

The Efficacy of Intense Pulsed Light and Suppurativa Treatment assesses the current level of evidence supporting this treatment for Hidradenitis suppurativa (HS), with a focus on a decrease in the number of lesions with associated HS flares.

Attitudes on, Practices, and Recommendations for Visible Light Protection Amongst Dermatology Practitioners aims to evaluate over 950+ dermatology practitioners’ counseling practices for visible light protection.

Find more JDD Issue Highlights here